Drugs / Measles-rubella
last change May 2025 re-read 2 minutes ago

Measles-rubella

Vaccine

Investigated by
Malaria Research and Training Center, Bamako, Mali · University of Oxford

Trials 1 · a red edge is where a trial was stopped

2023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT05155579 May 2022 → May 2025 malaria University of Oxford Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Measles-rubella ClinicalTrials.gov intervention name — accepted as the source's own label NCT05155579
Modality Vaccine “Licensed vaccine - Measles-rubella” NCT05155579